Patent details

EP1623712 Title: Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues

Basic Information

Publication number:
EP1623712
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP050181155
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues
French Title of Invention:
Combinaisons de modulateurs des récepteurs oestrogène et de déhydroépiandrostérone (DHEA) ou analogues
German Title of Invention:
Selektive Östrogenrezeptormodulatoren und Dehydroepiandrosterone (DHEA) oder Analoge als Kombination
SPC Number:

Dates

Filing date:
10/06/1999
Grant date:
12/12/2012
EP Publication Date:
12/12/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/02/2006
EP B1 Publication Date:
12/12/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/06/2017
Expiration date:
10/06/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/06/1999
 
 

Name:
ENDORECHERCHE INC.
Address:
2989 de la Promenade, Sainte-Foy, Quebec G1W 2J5, Canada (CA)

Inventor

Name:
Labrie Fernand
Address:
Canada (CA)

Priority

Priority Number:
96284
Priority Date:
11/06/1998
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/565;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
29/06/2016
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages